Tradestie Institutional Equity Comparison Engine

ADIL vs ACHV โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-09 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACHV Overall Edge

ACHV Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Achieve Life Sciences, Inc. (ACHV) driven by superior Valuation, Growth & Margin, Options & Structure while ADIL counters with relative strength in Momentum & Technical. Fundamentally, ADIL trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ACHV at 35.3x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ADIL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ACHV sits in BREAKOUT (23rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ACHV
ADIL N/M vs ACHV 35.3x Fwd P/E
Growth & Margin Winner ACHV
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner ADIL
1Y +1283.9% vs +43.0% ยท 52W Pos 70% vs 69%
Options & Structure Winner ACHV
UNCLASSIFIED (N/A IV) vs BREAKOUT (23rd %ile IV)
ADIL NASDAQ
Adial Pharmaceuticals, Inc
Pharmaceutical Preparations
$5.05
+36.12% 1D
Market Cap $9.7M
1M Return +21.69%
1Y Return +1283.94%
Forward P/E N/M
Unified AI Score
32.8 / 100 SELL
Tech 5.0 Fund 36.0 Flow 50.0 Mom 44.0
ACHV NASDAQ
Achieve Life Sciences, Inc.
In Vitro & In Vivo Diagnostic Substances
$6.78
+0.89% 1D
Market Cap $692.8M
1M Return -8.5%
1Y Return +43.04%
Forward P/E 35.3x
Unified AI Score
56.6 / 100 HOLD
Tech 66.0 Fund 58.0 Flow 57.0 Mom 58.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ADIL +1283.94% ACHV +43.04% Spread: +1399.83 pp (ADIL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ADIL TTM Op. Margin: 0.0% ACHV TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ADIL vs ACHV. Trailing 12-month operating profitability (ADIL 0.0% vs ACHV 0.0%) and valuation multiples (ADIL N/M vs ACHV 35.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ADIL (0) vs ACHV (6)
Institutional Metric ADIL ACHV Criterion Row Winner
Market Capitalization Scale $9.7M $692.8M Larger Scale ACHV
Trailing P/E Ratio Valuation N/M 35.3x Lower Multiple ACHV
Forward P/E Ratio Valuation N/M 35.3x Lower Multiple ACHV
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -2011.6% -845.0% Higher ROE ACHV
52-Week Range Position Momentum 70% ($0โ€“$7) 69% ($3โ€“$9) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 0.63ฮฒ ยท 153% Vol 1.73ฮฒ ยท 62% Vol Lower Realized Risk ACHV
Unified Institutional Score Composite Signal 32.8 / 100 (SELL) 56.6 / 100 (HOLD) Higher Composite ACHV

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ADIL vs ACHV Buy Guide
ADIL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ADIL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ACHV BREAKOUT
125d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 23rd %ile
IV Regime Compressed (<25th %ile)
Live ACHV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ADIL nor ACHV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.